A lifetime economic model of mortality and secondary care use for patients discharged from hospital following acute stroke.

IF 6.3 2区 医学 Q1 CLINICAL NEUROLOGY International Journal of Stroke Pub Date : 2024-09-10 DOI:10.1177/17474930241284447
Peter J McMeekin, Stephen McCarthy, Andrew McCarthy, Jennifer Porteous, Michael Allen, Anna Laws, Phil White, Martin A James, Gary A Ford, Lisa Shaw, Christopher I Price
{"title":"A lifetime economic model of mortality and secondary care use for patients discharged from hospital following acute stroke.","authors":"Peter J McMeekin, Stephen McCarthy, Andrew McCarthy, Jennifer Porteous, Michael Allen, Anna Laws, Phil White, Martin A James, Gary A Ford, Lisa Shaw, Christopher I Price","doi":"10.1177/17474930241284447","DOIUrl":null,"url":null,"abstract":"BackgroundThe long-term health-economic consequences of acute stroke are typically extrapolated from short-term outcomes observed in different studies, using models based on assumptions about longer-term morbidity and mortality. Inconsistency in these assumptions and the methods of extrapolation can create difficulties when comparing estimates of life-time cost-effectiveness of stroke care interventions.AimsTo develop a long-term model consisting of a set of equations to estimate the life-time effects of stroke care interventions to promote consistency in extrapolation of short-term outcomes.MethodsData about further admissions and mortality was provided for acute stroke patients discharged between 2013 and 2014 from a large English service. This was combined with data from UK life tables to create a set of parametric equations in a model that use age, sex, and modified Rankin Scores to predict the life-time risk of mortality and secondary care resource utilisation including ED attendances, non-elective admissions, and elective admissions. A cohort of 1,509 (male 51%; mean age 74) stroke patients had median follow-up of seven years and represented 7,111 post-discharge patient years. A logistic model estimated mortality within twelve months of discharge and a Gompertz model was used over the remainder of the lifetime. Hospital attendances were modelled using a Weibull distribution. Non-elective and elective bed days were both modelled using a log-logistic distribution.ResultsMortality risk increased with age, dependency, and male sex. Although the overall pattern was similar for resource utilisation, there were different variations according to dependency and gender for ED attendances and non-elective/elective admissions. For example, 65-year-old women with a discharge mRS of 1 would gain an extra 6.75 life years compared to 65-year-old women with a discharge mRS of 3. Over their lifetime, 65-year-old women with a discharge mRS of 1 would experience 0.09 less ED attendances, 2.12 less non-elective bed days and 1.28 additional elective bed days than 65-year-old women with a discharge mRS of 3.ConclusionsUsing long-term follow-up publicly available data from a large clinical cohort, this new model promotes standardised extrapolation of key outcomes over the life course, and potentially can improve the real-world accuracy and comparison of long-term cost-effectiveness estimates for stroke care interventions.Data Assess StatementData is available upon reasonable request from third parties.","PeriodicalId":14442,"journal":{"name":"International Journal of Stroke","volume":"37 1","pages":"17474930241284447"},"PeriodicalIF":6.3000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17474930241284447","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundThe long-term health-economic consequences of acute stroke are typically extrapolated from short-term outcomes observed in different studies, using models based on assumptions about longer-term morbidity and mortality. Inconsistency in these assumptions and the methods of extrapolation can create difficulties when comparing estimates of life-time cost-effectiveness of stroke care interventions.AimsTo develop a long-term model consisting of a set of equations to estimate the life-time effects of stroke care interventions to promote consistency in extrapolation of short-term outcomes.MethodsData about further admissions and mortality was provided for acute stroke patients discharged between 2013 and 2014 from a large English service. This was combined with data from UK life tables to create a set of parametric equations in a model that use age, sex, and modified Rankin Scores to predict the life-time risk of mortality and secondary care resource utilisation including ED attendances, non-elective admissions, and elective admissions. A cohort of 1,509 (male 51%; mean age 74) stroke patients had median follow-up of seven years and represented 7,111 post-discharge patient years. A logistic model estimated mortality within twelve months of discharge and a Gompertz model was used over the remainder of the lifetime. Hospital attendances were modelled using a Weibull distribution. Non-elective and elective bed days were both modelled using a log-logistic distribution.ResultsMortality risk increased with age, dependency, and male sex. Although the overall pattern was similar for resource utilisation, there were different variations according to dependency and gender for ED attendances and non-elective/elective admissions. For example, 65-year-old women with a discharge mRS of 1 would gain an extra 6.75 life years compared to 65-year-old women with a discharge mRS of 3. Over their lifetime, 65-year-old women with a discharge mRS of 1 would experience 0.09 less ED attendances, 2.12 less non-elective bed days and 1.28 additional elective bed days than 65-year-old women with a discharge mRS of 3.ConclusionsUsing long-term follow-up publicly available data from a large clinical cohort, this new model promotes standardised extrapolation of key outcomes over the life course, and potentially can improve the real-world accuracy and comparison of long-term cost-effectiveness estimates for stroke care interventions.Data Assess StatementData is available upon reasonable request from third parties.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
急性中风后出院患者死亡率和二级护理使用的终生经济模型。
背景急性卒中的长期健康经济后果通常是根据不同研究中观察到的短期结果推断出的,所使用的模型基于对长期发病率和死亡率的假设。这些假设和外推方法的不一致性会给比较卒中救治干预措施的终生成本效益估算值带来困难。方法提供了英国一家大型医疗机构 2013 年至 2014 年出院的急性卒中患者的进一步入院和死亡率数据。这些数据与英国生命表中的数据相结合,在一个模型中创建了一组参数方程,该模型使用年龄、性别和修正的兰金评分来预测患者终生的死亡风险和二级医疗资源利用率,包括急诊室就诊人次、非选择性入院和选择性入院。队列中有 1,509 名中风患者(男性占 51%;平均年龄 74 岁),中位随访时间为 7 年,代表出院后 7,111 个患者年。采用逻辑模型估算出院后 12 个月内的死亡率,并采用 Gompertz 模型估算剩余生命期的死亡率。住院人次采用 Weibull 分布模型。非选择性和选择性住院日均采用对数-逻辑分布建模。虽然资源利用的总体模式相似,但在急诊室就诊人次和非选择性/选择性入院人次方面,依赖性和性别差异不同。例如,与出院时 mRS 为 3 的 65 岁女性相比,出院时 mRS 为 1 的 65 岁女性可多活 6.75 年。与出院时 mRS 为 3 的 65 岁女性相比,出院时 mRS 为 1 的 65 岁女性一生中的急诊室就诊次数可减少 0.09 次,非选择性住院天数可减少 2.12 天,选择性住院天数可增加 1.28 天。结论利用来自大型临床队列的长期随访公开数据,这一新模型促进了生命过程中关键结果的标准化推断,并有可能提高中风护理干预措施长期成本效益估算的实际准确性和可比性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Stroke
International Journal of Stroke 医学-外周血管病
CiteScore
13.90
自引率
6.00%
发文量
132
审稿时长
6-12 weeks
期刊介绍: The International Journal of Stroke is a welcome addition to the international stroke journal landscape in that it concentrates on the clinical aspects of stroke with basic science contributions in areas of clinical interest. Reviews of current topics are broadly based to encompass not only recent advances of global interest but also those which may be more important in certain regions and the journal regularly features items of news interest from all parts of the world. To facilitate the international nature of the journal, our Associate Editors from Europe, Asia, North America and South America coordinate segments of the journal.
期刊最新文献
Prehospital blood pressure lowering in patients with ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Stroke recurrence after transcatheter PFO closure in patients with cryptogenic stroke. Advancing stroke safety and efficacy through early tirofiban administration after intravenous thrombolysis: The multicenter, randomized, placebo-controlled, double-blind ASSET IT trial protocol. Predictors of futile recanalization in ischemic stroke patients with low baseline NIHSS. Anticoagulation Usage and Thrombolytic Therapy in Subjects with Atrial Fibrillation Associated Ischaemic Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1